SHALINI SIRISENA: Open Payments
NPI 1508176306 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,021 in 124 payments from 25 companies in 2025. Trend: 2023 $1,570 · 2024 $1,686 · 2025 $2,021
Food & beverage: $2,021
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $323 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $252 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $241 |
| ABBVIE INC. | 11 | $156 |
| Novo Nordisk Inc | 11 | $153 |
| GlaxoSmithKline, LLC. | 8 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $96 |
| Exact Sciences Corporation | 4 | $80 |
| Astellas Pharma US Inc | 4 | $79 |
| InSightec,Inc | 2 | $73 |
Products named: Kerendia, XIFAXAN, BREZTRI, SHINGRIX, JARDIANCE, UBRELVY, FARXIGA, Veozah.
Industry payments across NY — which companies pay providers there.
